Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1999 Mar;52(3):219–224. doi: 10.1136/jcp.52.3.219

Development and validation of an assay for urinary tissue factor activity.

B A Lwaleed 1, M Chisholm 1, J L Francis 1
PMCID: PMC501083  PMID: 10450183

Abstract

BACKGROUND: Activation of blood coagulation is a common complication of cancer and inflammation in both humans and experimental animals. Increased production of tissue factor--the principal initiator of the coagulation process--by endothelial cells, monocytes, and macrophages has been implicated in these conditions. AIM: To investigate whether urinary tissue factor (uTF) might reflect the state of monocyte/macrophage activation and be a useful diagnostic test. METHODS: Urine was centrifuged at 51,000 g to sediment tissue factor containing membrane vesicles. The tissue factor was then solubilised in beta-octyl-glucopyranoside and assayed in a specific chromogenic assay adapted for use in microtitre plates. RESULTS: The assay proved to be sensitive, specific, and reproducible. The normal range of uTF was relatively narrow and unaffected by age, sex, or cigarette smoking. Levels were not significantly influenced by storage of urine samples before assay or by the presence of fresh blood in the urine sample. CONCLUSIONS: This method may have diagnostic application in the study of haemostatic activation in patients with cancer and other disease states.

Full text

PDF
219

Images in this article

221Image
on p.221
222Image
on p.222

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adamson A. S., Francis J. L., Roath O. S., Witherow R. O., Snell M. E. Urinary tissue factor levels in transitional cell carcinoma of the bladder. J Urol. 1992 Aug;148(2 Pt 1):449–452. doi: 10.1016/s0022-5347(17)36626-0. [DOI] [PubMed] [Google Scholar]
  2. Adamson A. S., Francis J. L., Witherow R. O., Snell M. E. Urinary tissue factor levels in prostatic carcinoma: a potential marker of metastatic spread? Br J Urol. 1993 May;71(5):587–592. doi: 10.1111/j.1464-410x.1993.tb16030.x. [DOI] [PubMed] [Google Scholar]
  3. Amlie E., Lyberg T., Kaplun A., Hetland O., Prydz H. Thromboplastin activity of mouse peritoneal macrophages. Thromb Res. 1981 Oct 1;24(1-2):61–71. doi: 10.1016/0049-3848(81)90032-3. [DOI] [PubMed] [Google Scholar]
  4. Aoki N., Von Kaulla K. N. The procoagulant in human urine: purification, assay and some biochemical and physiological properties. Thromb Diath Haemorrh. 1966 Dec 1;16(3):586–605. [PubMed] [Google Scholar]
  5. Bach R., Gentry R., Nemerson Y. Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine. Biochemistry. 1986 Jul 15;25(14):4007–4020. doi: 10.1021/bi00362a005. [DOI] [PubMed] [Google Scholar]
  6. Barlow G. H., Firestone S. L., Robbins K. C. Identification of the plasminogen activator(s) produced by the transformed liver cell line, SK-HEP-1. Thromb Res. 1983 Oct 1;32(1):29–34. doi: 10.1016/0049-3848(83)90151-2. [DOI] [PubMed] [Google Scholar]
  7. Becker C. G., Dubin T. Activation of factor XII by tobacco glycoprotein. J Exp Med. 1977 Aug 1;146(2):457–467. doi: 10.1084/jem.146.2.457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Calmus Y., Robert A. Increase in monocyte procoagulant activity with age. Thromb Res. 1986 Jan 1;41(1):133–136. doi: 10.1016/0049-3848(86)90286-0. [DOI] [PubMed] [Google Scholar]
  9. Carson S. D. Continuous chromogenic tissue factor assay: comparison to clot-based assays and sensitivity established using pure tissue factor. Thromb Res. 1987 Aug 15;47(4):379–387. doi: 10.1016/0049-3848(87)90453-1. [DOI] [PubMed] [Google Scholar]
  10. Carson S. D., Konigsberg W. H. Lipid activation of coagulation factor III apoprotein (tissue factor)--reconstitution of the protein-membrane complex. Thromb Haemost. 1980 Aug 29;44(1):12–15. [PubMed] [Google Scholar]
  11. Carty N., Taylor I., Roath O. S., el-Baruni K., Francis J. L. Urinary tissue factor activity in colorectal disease. Br J Surg. 1990 Oct;77(10):1091–1094. doi: 10.1002/bjs.1800771005. [DOI] [PubMed] [Google Scholar]
  12. Carty N., Taylor I., Roath O. S., el-Baruni K., Francis J. L. Urinary tissue factor activity in malignancy. Thromb Res. 1990 Feb 1;57(3):473–478. doi: 10.1016/0049-3848(90)90263-c. [DOI] [PubMed] [Google Scholar]
  13. Dover R., Goeting N. L., Taylor I., Roath O. S., Francis J. L. Factor X-activating activity in patients with colorectal carcinoma. Br J Surg. 1987 Dec;74(12):1122–1124. doi: 10.1002/bjs.1800741216. [DOI] [PubMed] [Google Scholar]
  14. Gordon S. G., Franks J. J., Lewis B. Cancer procoagulant A: a factor X activating procoagulant from malignant tissue. Thromb Res. 1975 Feb;6(2):127–137. doi: 10.1016/0049-3848(75)90018-3. [DOI] [PubMed] [Google Scholar]
  15. Joist H., Alkjaersig N. Uroplastin, its nature and its excretion pattern in health and in certain disease states. Thromb Diath Haemorrh. 1967 Dec 31;18(3-4):425–432. [PubMed] [Google Scholar]
  16. Krupski W. C., Bass A., Dilley R. B., Bernstein E. F., Otis S. M. Propagation of deep venous thrombosis identified by duplex ultrasonography. J Vasc Surg. 1990 Oct;12(4):467–475. [PubMed] [Google Scholar]
  17. Lorenzet R., Peri G., Locati D., Allavena P., Colucci M., Semeraro N., Mantovani A., Donati M. B. Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues. Blood. 1983 Aug;62(2):271–273. [PubMed] [Google Scholar]
  18. Matsuda M., Aoki N., Kawaoi A. Localization of urinary procoagulant in the human kidney. Kidney Int. 1979 Jun;15(6):612–617. doi: 10.1038/ki.1979.80. [DOI] [PubMed] [Google Scholar]
  19. Matsumura T., Hutt M. P., von Kaulla K. N. Urinary procoagulant excretion and its relation to kidney function. Nephron. 1970;7(2):165–177. doi: 10.1159/000179818. [DOI] [PubMed] [Google Scholar]
  20. Matsumura T., Von Kaulla K. N. Procoagulant content of human urine in health and disease. Am J Clin Pathol. 1968 Aug;50(2):198–210. doi: 10.1093/ajcp/50.2.198. [DOI] [PubMed] [Google Scholar]
  21. Mellor H., Taylor I., Roath S., Francis J. L. Whole blood procoagulant activity in breast and colorectal cancer. J Clin Pathol. 1989 May;42(5):489–494. doi: 10.1136/jcp.42.5.489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Mussoni L., Conforti G., Gambacorti-Passerini C., Alessio G., Pepe S., Vaghi M., Erba E., Amato G., Landoni F., Mangioni C. Procoagulant and fibrinolytic activity of human ovarian carcinoma cells in culture. Eur J Cancer Clin Oncol. 1986 Apr;22(4):373–380. doi: 10.1016/0277-5379(86)90101-x. [DOI] [PubMed] [Google Scholar]
  23. Parmar J., Taylor I., Roath S., Francis J. Procoagulant activity in whole blood from patients with breast and colorectal cancer. Blood Coagul Fibrinolysis. 1990 Jun;1(2):127–132. [PubMed] [Google Scholar]
  24. Pusey M. L., Mende T. J. Studies on the procoagulant activity of human amniotic fluid. II. The role of factor VII. Thromb Res. 1985 Sep 1;39(5):571–585. doi: 10.1016/0049-3848(85)90237-3. [DOI] [PubMed] [Google Scholar]
  25. Rickles F. R., Edwards R. L., Barb C., Cronlund M. Abnormalities of blood coagulation in patients with cancer. Fibrinopeptide A generation and tumor growth. Cancer. 1983 Jan 15;51(2):301–307. doi: 10.1002/1097-0142(19830115)51:2<301::aid-cncr2820510223>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  26. Rickles F. R., Rick P. D. Structural features of Salmonella typhimurium lipopolysaccharide required for activation of tissue factor in human mononuclear cells. J Clin Invest. 1977 Jun;59(6):1188–1195. doi: 10.1172/JCI108743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Sun N. C., McAfee W. M., Hum G. J., Weiner J. M. Hemostatic abnormalities in malignancy, a prospective study of one hundred eight patients. Part I. Coagulation studies. Am J Clin Pathol. 1979 Jan;71(1):10–16. doi: 10.1093/ajcp/71.1.10. [DOI] [PubMed] [Google Scholar]
  28. Wiggins R., Glatfelter A., Kshirsagar B., Beals T. Lipid microvesicles and their association with procoagulant activity in urine and glomeruli of rabbits with nephrotoxic nephritis. Lab Invest. 1987 Mar;56(3):264–272. [PubMed] [Google Scholar]
  29. Zacharski L. R., Rosenstein R., Phillips P. G. Concanavalin A inhibition of tissue factor (thromboplastin) activity. Blood. 1974 Dec;44(6):783–787. [PubMed] [Google Scholar]
  30. van der Salm P., Ubachs H. M., van Wersch J. W. Cord blood clotting factors in neonates of smoking and non-smoking mothers. Int J Clin Lab Res. 1994;24(3):177–179. doi: 10.1007/BF02592450. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES